Literature DB >> 20015188

Borrelia in granuloma annulare, morphea and lichen sclerosus: a PCR-based study and review of the literature.

Therese Zollinger1, Kirsten D Mertz, Mirka Schmid, Anja Schmitt, Madeleine Pfaltz, Werner Kempf.   

Abstract

BACKGROUND: Morphea, granuloma annulare (GA) and lichen sclerosus et atrophicans (LSA) have also been suggested to be linked to Borrelia infection. Previous studies based on serologic data or detection of Borrelia by immunohistochemistry and polymerase chain reaction (PCR) reported contradictory results. Thus, we examined skin biopsies of morphea, GA and LSA by PCR to assess the prevalence of Borrelia DNA in an endemic area and to compare our results with data in the literature.
METHODS: Amplification of DNA sequences of Borrelia burgdorferi sensu lato by nested PCR from formalin-fixed and paraffin-embedded skin biopsies of morphea, GA and LSA, followed by automated sequencing of amplification products. PCR-based studies on Borrelia species in these disorders published until July 2009 were retrieved by a literature search.
RESULTS: Borrelia DNA was detected in 3 of 112 skin biopsies (2.7%) including one of 49 morphea biopsies (2.0%), one of 48 GA biopsies (2.1%) and one of 15 LSA biopsies (6.6%). Amplification products belonged to B. burgdorferi sensu stricto in two cases available for sequence analysis.
CONCLUSIONS: The results of our and most of other PCR-based studies do not argue for a significant association of B. burgdorferi sensu lato with morphea, GA, LSA.

Entities:  

Mesh:

Year:  2009        PMID: 20015188     DOI: 10.1111/j.1600-0560.2009.01493.x

Source DB:  PubMed          Journal:  J Cutan Pathol        ISSN: 0303-6987            Impact factor:   1.587


  12 in total

1.  Borrelia burgdorferi Infections in the United States.

Authors:  Warren R Heymann; Dana L Ellis
Journal:  J Clin Aesthet Dermatol       Date:  2012-08

2.  Morphea on the breast after a needle biopsy.

Authors:  Noriko Arase; Ken Igawa; Satoko Senda; Mika Terao; Hiroyuki Murota; Ichiro Katayama
Journal:  Ann Dermatol       Date:  2011-12-27       Impact factor: 1.444

3.  [Localized scleroderma (morphea) in childhood].

Authors:  L Weibel
Journal:  Hautarzt       Date:  2012-02       Impact factor: 0.751

4.  Treatment with Doxycycline of Generalized Annular Elastolytic Giant Cell Granuloma Associated with Borrelia burgdorferi Infection.

Authors:  B Tas; A Caglar; B Ozdemir
Journal:  West Indian Med J       Date:  2015-05-05       Impact factor: 0.171

5.  Evaluation of skin thickness lesions in patients with Lyme disease measured by modified Rodnan total skin score.

Authors:  A Moniuszko; E Gińdzieńska-Sieśkiewicz; S A Pancewicz; P Czupryna; J Zajkowska; S Sierakowski
Journal:  Rheumatol Int       Date:  2011-09-30       Impact factor: 2.631

Review 6.  Development of minimum standards of care for juvenile localized scleroderma.

Authors:  Tamás Constantin; Ivan Foeldvari; Clare E Pain; Annamária Pálinkás; Peter Höger; Monika Moll; Dana Nemkova; Lisa Weibel; Melinda Laczkovszki; Philip Clements; Kathryn S Torok
Journal:  Eur J Pediatr       Date:  2018-05-04       Impact factor: 3.183

7.  Lichen sclerosus et atrophicans, scleroderma en coup de sabre and Lyme borreliosis.

Authors:  Nicoletta Gubertini; Serena Bonin; Giusto Trevisan
Journal:  Dermatol Reports       Date:  2011-09-28

Review 8.  Diagnosis and treatment of lichen sclerosus: an update.

Authors:  Susanna K Fistarol; Peter H Itin
Journal:  Am J Clin Dermatol       Date:  2013-02       Impact factor: 7.403

9.  Michel's Transport Medium as an Alternative to Liquid Nitrogen for PCR Analysis of Skin Biopsy Specimens.

Authors:  Logeina Boraiy; Lionel Fontao
Journal:  Dermatopathology (Basel)       Date:  2014-10-24

10.  Skin and mucous membranes' manifestations of dermatological diseases within the genital area in females.

Authors:  Katarzyna Plagens-Rotman; Renata Przybylska; Zygmunt Adamski; Magdalena Czarnecka-Operacz
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.